Gümüş Güler, BaşakÖzler, Sibel2020-08-302020-08-302020Güler, B. G., & Özler, S. (2020). Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis. Hepatobiliary & Pancreatic Diseases International, 19(3), 271-276.1499-38722352-9377https://doi.org/10.1016/j.hbpd.2019.12.001https://hdl.handle.net/20.500.12713/396Intrahepatic cholestasis of pregnancy (ICP) increases the risk of adverse pregnancy outcomes. This study aimed to explore the association between serum syndecan-1 and glypican-3 levels and the adverse perinatal outcome as well as the responses to the treatment of ursodeoxycholic acid (UDCA).eninfo:eu-repo/semantics/closedAccessArticle19327127631919038WOS:0005413816000102-s2.0-85077371721Q310.1016/j.hbpd.2019.12.001Q2